Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 27, 2026ACS Nano

A Bioinspired Exosomal Nanoplatform for Coordinated Sorafenib and MicroRNA Delivery to Sensitize Ferroptosis and Induce Immunoactivation in Triple-Negative Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

YWYiyi WangXZXi ZhangXXXi-Yuan Xu

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates enhanced tumor targeting and immunoactivation in triple-negative breast cancer, suggesting a novel therapeutic approach.

Key Points

  • The aim is to create a bioinspired exosomal nanoplatform for targeted delivery of sorafenib and microRNAs to enhance treatment in triple-negative breast cancer.
  • Developed Sor@AKAExo using Anoectochilus roxburghii-derived exosomes.
  • Functionalized with AS1411 aptamer for tumor targeting; conjugated with KLA peptide for mitochondrial localization.
  • Evaluated synergistic effects on ferroptosis and apoptosis in vivo.
  • Sor@AKAExo shows potent antitumor efficacy with GPX4 suppression, lipid peroxidation, and caspase-3 activation.
  • Exosomal miRNAs downregulated the MAPK pathway and upregulated IL-17 and cholesterol metabolism pathways, enhancing treatment effects.
  • Demonstrated excellent biosafety while addressing challenges of drug resistance in TNBC.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/69eefcaefede9185760d39aehttps://doi.org/10.1021/acsnano.6c02310
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NK cell vesicles-based nanoplatform loaded with sorafenib synergizing ferroptosis and antitumor immunity against hepatocellular carcinoma2026 · 1 citations
  2. 2Synergistic epigenetic modulation and ferroptosis induction via codelivery of Decitabine and Sorafenib for potent anti-tumor therapy2026
  3. 3Wearable microneedle-delivered homotypic exosomes sensitize ferroptosis for triple-negative breast cancer therapy2026
  4. 4A bioinspired catalytic nanoplatform for ferroptosis‐immunotherapy synergy in metastatic cancer2026
  5. 5Tumor‐targeted and microenvironment‐activatable iron‐based nMOF for synergistic inducing ferroptosis2024 · 1 citations